A carregar...
Targeting ALK: the ten lives of a tumor
In this issue, Mossé and coworkers report the results of preclinical testing of a novel ALK/ROS1 inhibitor, PF06463922 in neuroblastoma. This small molecule inhibitor was shown to efficiently inhibit the growth of patient-derived and established neuroblastoma xenograft models expressing mutated ALK....
Na minha lista:
| Publicado no: | Cancer Discov |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4709027/ https://ncbi.nlm.nih.gov/pubmed/26747894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-15-1411 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|